Clinical Trial Update: Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 influenza vaccine pilot conducted within the Atopic Dermatitis Research Network has completed; the study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | EARLY_Phase 1 | Status: COMPLETED